Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-050587

Director sold 2,250 shares at $20.24 ($45,540)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ajer Jeffrey Robert Director 2019-09-20 Sale −2,250 $20.24 $45,540 18,250 D
Open-market sales · 2,250 sh · avg $20.24 · $45,540
Loading xslF345X03/doc4.xml…